1 2  

Martin Godbout

Martin Godbout, O.C., PhD

Chair of the Board

Following a brief academic career at Université Laval in the early 90s, Martin Godbout was named President and General Manager of Société Innovatech Québec. In 1997, he pursued his career in the biopharmaceutical venture capital sector as Senior Vice President of BioCapital. In May 2000, he became the founding President and CEO of Genome Canada, which he led for nearly 10 years.


Officer of the Order of Canada, Mr. Godbout is currently Chair of the Board of AmorChem-1, BioContact, BIOQuebec and Genome Quebec. He is also an independent Board member of the following organizations: AngioChem, Fonds de recherche du Québec - Santé, P3G, Ataxia Charlevoix-Saguenay Fondation, Leucodystrophies Fondation and Baie-Saint-Paul Hospital Fondation.


Mr. Godbout holds a PhD in Physiology and Molecular Endocrinology from Université Laval and completed a postdoctoral training in neuromolecular biology at the Scripps Research Institute, in San Diego. In 2016, he was named Grand Diplômé from Université Laval.

Marie-Josée Blais

Marie-Josée Blais


Assistant Deputy Minister, ministère de l'Économie, de la Science et de l'Innovation

Me Jean Brunet

Me Jean Brunet

Secretary of the Board

Managing Partner of Stein Monast L.L.P.


Jean Brunet specializes in corporate and commercial law, including the negotiation and drafting of business purchase and sales agreements, mergers, corporate reorganizations and shareholders’ agreements. Mr. Brunet also practises intellectual property law, including negotiating and drafting research contracts, distribution agreements, and licence and technology transfer agreements, mainly in the sectors of pharmaceuticals, genomics, proteomics, bioinformatics and biotechnology.


In addition, Mr. Brunet acts as legal counsel and corporate secretary for various companies, particularly in the areas of biotechnology, genomics and proteomics, including active involvement on the boards of Genome Canada and Génome Québec. His duties include advising these companies on corporate governance policies and compliance matters. Mr. Brunet is one of the founders and directors of BioContact, an annual biotechnology symposium.

Daniel Coderre

Daniel Coderre, PhD

President and CEO

A certified corporate director (ASC - Administrateur de sociétés certifié) Daniel Coderre has a proven track record in public administration. He served as Rector of the Institut national de la recherche scientifique (INRS) since 2009, where he acquired solid expertise in public administration and built a wide network of partners. Mr. Coderre holds a doctorate in biology from the Université de Sherbrooke. He began his career in 1982 as a biology professor at UQAM, where he supervised 85 masters and doctoral students and published nearly 100 scientific publications. He also served as Dean of the Faculty of Science and Vice-Rector of Research before being appointed Vice-President of Academic Affairs and Research from 2004 to 2009 and in 2009, as its Interim President. He has held positions on close to twenty committees, boards of directors, scientific, government and international committees and various commissions on science, technology and innovation. 

Sophie D'Amours

Sophie D'Amours, Eng., PhD

Sophie D’Amours, a professor in the Department of Mechanical Engineering at Université Laval since August 1995, has a wealth of experience in higher learning, research and university management, both here and abroad. She has held the Canada Research Chair in Planning Sustainable Forest Value Networks since 2009. Her research focuses on business engineering, value chain management and decision-making processes in the forestry sector. Ms. D’Amours was Founding Director of the FORAC Research Consortium (2002–2011) and Scientific Director of the Strategic Research Network on Value Chain Optimization for the Natural Sciences and Engineering Research Council (NSERC) (2009–2014).

Over the past three years, she has served as Vice-Rector, Research and Innovation at Université Laval. During her tenure, she successfully led the “Sentinel North” bid under the Canada First Research Excellence Fund, earning the University $98 million in funding, the largest research grant of its history. She has served as Chairperson of the Board of the Centre de recherche industrielle du Québec since 2010 and serves on the Board of Directors of the Société québécoise des infrastructures and of the NSERC. She has been a member of the Institut agronomique, vétérinaire et forestier de France strategic orientation committee since 2016. In 2015, she co-managed the strategic planning process for the NSERC and has been a guest lecturer in many universities around the world. In 2008, the Ordre des ingénieurs forestiers du Québec awarded her the Henri-Gustave-Joly-de-Lotbinière prize for her outstanding contribution to the forestry sector. She also received a recognition award from the YWCA and, with her colleagues, earned the prestigious Brockhouse Canada Prize. 

Hélène Desmarais

Hélène Desmarais, C.M., LL.D.

CEO and Chair of the Board of Administration, Centre d'entreprises et d'innovation de Montréal


Founder, CEO and Chair of the Board of Administration of the Centre d'entreprises et d'innovation de Montréal (CEIM) since 1996, Ms. Hélène Desmarais holds a Bachelor of Business Administration in finance from HEC Montréal. CEIM is a business incubator, with an emphasis on startups as well as the development of innovative IT, multimedia, industrial technology and biotech companies. CEIM supports the emergence of viable, innovative and successful companies from those sectors which are an economic priority for the Greater Metropolitan Area of Montréal and the province of Québec.


 Ms. Desmarais is founder and Chair of the Board of Administration and of the Entrepreneurial Development Committee of the Société de développement économique Ville-Marie (SDEVM) since 1998. She is both Chair of the Board of Administration and of the Financial Assistance Committee of the SDEVM's Société d'Investissement Jeunesse (SIJ) Loan Guarantee Program. The primary mission of these two organisations is to promote entrepreneurship and economic development. The SDEVM primarily offers commercial loan guarantees to startup companies. The SIJ offers personal loan guarantees to young entrepreneurs under 35, who wish to start, acquire or become an associate in a Québec business.


Gestion Bio-Capital Inc. was founded in 1997 and was led by Ms. Desmarais as Chair of the Board of Administration until the sale of the fund in 2001. She was also a member of the verification and investment committees and member of the private investment evaluation committee at the time of the sale of the fund. Gestion Bio-Capital Inc. was a venture capital organisation specializing in biotech startups.


In 2003, Ms. Desmarais was appointed first female President of HEC's Board of Administration, to which she had been named in 1999. She is Co-President and founder of the International Advisory Board of HEC Montréal (1990), is chair of the University of Montreal's Faculty of Medicine Advisory Committee (2006), is chair of the advisory board of the Consultative Committee of the Hospital Centre of the Université de Montréal (CHUM) (2008), is President of the Advisory Board and member of the Board of Governors of the Conference of Montreal (International Economic Forum of the Americas, 1995), is President of the Board of Administration of The Montreal Economic Institute (2007) where she has held a seat since 2002, is Chair of the Canadian Joint Regional Committees since 2006, was President of the Board of Directors of the Board of Trade of Metropolitan Montreal. She was on the Board of Trade of Metropolitan Montreal from 2002-2009 and has sat on its Executive Committee since 2005. She has been Deputy Chair of the Montreal Symphony Orchestra and Chair and founder of its Fondation since 2008.  She chaired a commission formed by the Province of Quebec to study the healthcare industry (1997). 


Ms. Desmarais also sits on the following Boards of administrations : Garda World Security Corporation (2006); C.D. Howe Institute (2005); the Institute for Governance of Private and Public Organizations (2005); of the IRCM - The Institut de recherches cliniques de Montréal (2005), of Génome Québec (2002), of VAL-CHUM -- Société de valorisation des recherches du CHUM (2004). She is a member of the Conseil des partenaires de l'innovation (CIP), which falls under the aegis of Quebec's Ministry of Développement économique, Innovation et Exportation (2006), of the City of Montreal Economic Orientation Committee (2005), of the advisory board of Biotechnology Research Iinstitute, National Research Council of Canada (1998-2001) and of the Investment Committee, Hydro-Quebec CapiTech - Innovation Fund (2001-2004).


Recipient, Queen Elizabeth II’s Golden Jubilee Medal 2002; Order of Merit, Université de Montréal 2007; Medal of Honour, Faculty of Medicine of the Université de Montréal 2009; Doctor of Laws honoris causa, St. Francis Xavier University 2009; Order of Canada, Chancellery of Honours 2009; Prix entrepreneurship of Conseil du Patronat du Québec 2010; Grande Montréalaise (economic sector), Académie des grands montréalais and la Chambre de commerce du Montréal métropolitain 2010. 

Marc LePage

Marc LePage


President and CEO, Genome Canada


Marc LePage was appointed President and CEO of Genome Canada December 2015. Before this, he served as President and CEO of Génome Québec since December 2011, where he led a major increase in research activity and enhanced focus on the development of genomic applications within priority sectors within the province.  

He brings a wealth of experience in the innovation sector and venture capital, in addition to a broad network of international contacts.

He is an expert in international partnerships and previously served as Special Advisor, Climate Change and Energy for the Embassy of Canada in Washington, D.C. and worked as Consul General at the Canadian Consulate in San Francisco/Silicon Valley.

Marc LePage was also one of the pioneers behind the founding of Genome Canada in 2000. During his tenure as Executive Vice-President of Corporate Development, he made a significant contribution to the development of genomics in Canada.

From 1994 to 2000, he worked as Director of Business Development for the Medical Research Council, where he was in charge of building international partnerships with the pharmaceutical industry, venture capital and foundations.

Marc LePage is a member of the Board and the Governance Committee of the Quebec Network for Personalized Health Care. He also sits on the Board of Canada World Youth.

Marie-Lucie Morin

Marie-Lucie Morin

Marie-Lucie Morin took up her functions as Executive Director for Canada, Ireland and the Caribbean at the World Bank in November 2010. She was appointed National Security Advisor to the Prime Minister of Canada and Associate Secretary to the Cabinet in November 2008. From April 2006 to November 2008, she served as Deputy Minister of International Trade and from December 2003 to April 2006, as Associate Deputy Minister of Foreign Affairs. Prior to this appointment, she held the post of Assistant Deputy Minister, International Business, and Chief Trade Commissioner.

Mrs. Morin has extensive experience abroad, acquired during postings to San Francisco, Jakarta, London and Moscow. In 1997, she was appointed as Canada's Ambassador to the Kingdom of Norway with concurrent accreditation to the Republic of Iceland, a position she held until 2001.

From its creation in 2007 until 2009, Mrs. Morin was a member of the Science, Technology and Innovation Council of Canada (STIC). She also served on the Board of the Canadian Commercial Corporation. Since early 2012, she is a member of the Advisory Panel on Open Government presided by the President of the Treasury Board of Canada.

Mrs. Morin was awarded the Governor General’s 125th Anniversary of the Confederation of Canada Medal in 1992. In 2011, she received the Association of Professional Executives of the Public Service of Canada’s (APEX) Global Public Servant Award and was made “Chevalier de la Légion d’Honneur” (France) in 2012.
Mrs. Morin was born in Sherbrooke, Quebec, in 1957. She graduated with her Licentiate in Laws from the Université de Sherbrooke and in 1980, she was admitted to the Barreau du Québec.

Mrs. Morin is married to Nicolas Temnikov; they have one daughter and three sons.

Anie Perrault

Anie Perrault, LL.L., ASC

Executive Manager, BIOQuébec

An attorney by training, Anie Perrault is currently Executive Manager of BIOQuébec and a part-time member (administrative judge) of the Canadian Human Rights Tribunal. She was a City Councillor for the City of Bromont from 2009 to 2015. In February 2013, Ms. Perrault received the title of Administratrice de sociétés certifiée (ASC) (certified corporate director) from Collège des administrateurs de sociétés of Université Laval. She sits on the Loto-Québec and the Université de Sherbrooke (September 2016) Boards of Directors and served on the Research and Ethics Committee for Génome Québec from 2014 to 2016.

From 2006 to 2011, she was President of her own communications firm, Communications Anie Perrault, and from 2001 to 2006, she held the position of Vice President of Communications at Genome Canada. Previously, she was National Director of Communications and Public Affairs for Canada’s Research-Based Pharmaceutical Companies (Rx&D). From 1998 to 2000, Ms. Perrault was Press Officer, Director of Communications and Senior Advisor to the Right Honourable Joe Clark. Additionally, she was Policy Advisor to various Members of Parliament from 1989 to 1992 and from 1995 to 1998. From 1992 to 1995, Ms. Perrault practised law in Montréal at Davis Ward Phillips & Vineberg.

Rémi Quirion

Rémi Quirion, O.C., PhD, FRSC, CQ

Chief Scientist of Québec


Professor Rémi Quirion is Chief Scientist of Québec following the implementation of Bill 130 on July 1, 2011, which merged Québec’s three research funds. A full professor in McGill’s Department of Psychiatry, Professor Quirion served as Scientific Director at the Douglas Mental Health University Institute from 1996 to 2011. In April 2009, he took up the position of Vice Dean (Life Sciences and Strategic Initiatives), Faculty of Medicine, as well as Senior University Advisor (Health Sciences Research) at McGill University, in addition to serving as the CIHR Executive Director, International Collaborative Research Strategy for Alzheimer's Disease. He withdrew from these positions following his nomination as Québec’s Chief Scientist.


Since 1996, under his leadership, the Douglas Research Centre became a premier research facility in Canada in the fields of neurosciences and mental health. Professor Quirion promoted the development of neurosciences and clinical research in neurology and psychiatry, as well as the social aspects and evaluation of research in mental health and addiction. His research interests include: a) understanding the relationships between key phenotypes of the Alzheimer's brain and b) molecular and pharmacological features of neuropeptide receptors focusing on NPY and CGRP, and their role in memory, pain and drug dependence, and in animal models of schizophrenia.He has a keen interest for training the next generation of scientists, having mentored over 20 doctoral students and 50 postdoctoral students, who currently work around the world. In addition to sitting on the advisory boards of over 15 scientific journals in psychiatry, pharmacology, and neurosciences, Professor Quirion has published 5 books, over 600 scientific papers and articles.


From 2000 to 2009, Professor Quirion was the first Scientific Director of the Institute of Neurosciences, Mental Health and Addiction (INMHA), one of the 13 virtual institutes of the Canadian Institutes of Health Research created in 2000. He is also one of the most highly cited neuroscientists in the world and a Fellow of the Royal Society of Canada. In 2003, he was named “Chevalier” of the Ordre national du Québec and received the Médaille de l’Assemblée nationale du Québec and the First Annual Award – National Mental Health Champion (Research). In 2004, he was honoured with the Québec Wilder-Penfield Award, the highest distinction in biomedical research in Québec as well as the Heinz Lehmann Award of the Douglas Hospital Foundation and the Dr. Mary V. Seeman Award from the Canadian Psychiatric Research Foundation. In 2005, he was appointed Fellow of the Canadian Academy of Health Sciences here at home and awarded an Honoris Causa Doctorate from the Central South University of China, Changsha, Hunan, which ranks among the country’s top 15 universities out of 2000; he also became a member of this university’s Academic Committee, a mandate that lasted until December 2010.


In 2007 Professor Quirion became a Member of the Order of Canada (O.C.) in recognition of his prolific scientific career. His latest distinctions include the Schizophrenia Society of Canada’s 2007 Pacesetter Award; the Canadian College of Neuropharmacology 2007 Medal for his exemplary career and exceptional contribution to neuropsychopharmacology in Canada through training, education and administration; the 2007 Prix Michel Sarrazin of the Club de recherches cliniques du Québec and the Verdun “Tip of the Hat” prize for international distinction awarded by the Verdun Economic Forum. In 2010 Professor Quirion was honoured with an Honoris Causa Doctorate from the Institut National de la Recherche in Québec City and in 2011 received yet another Honoris Causa Doctorate, Honorary Doctor of Laws, this time from Montréal’s Concordia University.

1 2  

Newsletter subscription

Subscribe to our newsletter and be the first to find out the latest news.